In NSCLC, increased tumor infiltration with CD8+ T cells is associated with improved survival 25, whereas higher infiltration by FOXP3+ Treg cells is associated with disease recurrence 26. The gene discussed is FOXP3; the disease is non-small cell lung carcinoma.